Compare RGS & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGS | ZTEK |
|---|---|---|
| Founded | 1922 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 78.2M |
| IPO Year | 1991 | N/A |
| Metric | RGS | ZTEK |
|---|---|---|
| Price | $24.90 | $0.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.9K | ★ 85.9K |
| Earning Date | 02-11-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.05 | N/A |
| EPS | ★ 45.08 | N/A |
| Revenue | ★ $223,032,000.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.58 | ★ N/A |
| Revenue Growth | 13.98 | ★ 2225.73 |
| 52 Week Low | $15.00 | $0.62 |
| 52 Week High | $31.50 | $1.84 |
| Indicator | RGS | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 36.92 | N/A |
| Support Level | $24.39 | N/A |
| Resistance Level | $25.53 | N/A |
| Average True Range (ATR) | 0.99 | 0.00 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 26.76 | 0.00 |
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.